Fasken represented Research Capital Corporation in the offering.Algernon Pharmaceuticals Inc. (“Algernon” or “the Company”), a Canadian clinical stage pharmaceutical development company, completed a rights offering of…
Algernon Pharmaceuticals’ C$1.1 Million Rights Offering
